Troponin I and lactate from coronary sinus predict cardiac complications after myocardial revascularization

Francesco Onorati1, Lucia Cristodoro, Santo Caroleo

  • 1Cardiac Surgery Unit, Magna Graecia University, Catanzaro, Italy. frankono@libero.it

Insights

Elevated troponin I and lactate levels after myocardial revascularization predict cardiac complications. Early intraoperative monitoring can help prevent acute myocardial infarction and myocardial damage.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biochemistry

Background:

  • Postoperative elevation of troponin I and lactate are associated with cardiac complications following myocardial revascularization.
  • Early prediction of acute myocardial infarction (AMI) and myocardial damage is crucial after cardiac surgery.

Purpose of the Study:

  • To evaluate the predictive value of troponin I and lactate levels for acute myocardial infarction (AMI) and myocardial damage after myocardial revascularization.
  • To assess the utility of intraoperative and postoperative biochemical markers in predicting cardiac complications.

Main Methods:

  • 183 patients undergoing isolated myocardial revascularization were prospectively studied.
  • Troponin I and lactate levels were measured preoperatively, intraoperatively, and at 12, 24, 48, and 72 hours postoperatively.
  • Receiver operating characteristic (ROC) curves were used to determine the predictive accuracy of troponin I and lactate for AMI and myocardial damage.

Main Results:

  • Patients who developed AMI (3.2%) or myocardial damage (3.2%) had significantly higher troponin I and lactate levels at all measured time points.
  • Coronary sinus troponin I demonstrated superior predictive accuracy for AMI (AUC 0.820) and myocardial damage (AUC 0.834) compared to lactate.
  • Elevated troponin I and lactate were associated with longer intubation times, intensive care unit stays, hospital stays, and worse ventricular function.

Conclusions:

  • Coronary sinus troponin I and lactate levels are valuable predictors of cardiac complications after myocardial revascularization.
  • Routine intraoperative biochemical monitoring of troponin I and lactate should be implemented to facilitate preventative strategies and reduce myocardial damage.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...